marcus evans europe conferences

11th Edition Biologics Formulation Development and Drug Delivery

Foster the stability and robustness of your formulation through all the processes to ensure a safe delivery to patients

22-23 October 2020
Virtual, Live+


Why You Should Attend

11th Edition Biologics Formulation Development and Drug Delivery

This marcus evans event will provide attendees with a more coherent, efficient, and comprehensive view on the whole formulation process (from preformulation through to production, manufacturing, and delivery). They will benefit from case studies on major challenges such as aggregates, particles, bioavailability, immunogenicity, and compatibility; and will learn how to minimise risks, time, and expenditure.

Protein formulation development is a challenging process which ultimately determines the effectiveness and profitability of the final protein drug. Proteins are complex and fragile molecules which are not easy to identify, comprehend, and most of all, to stabilise in the long term. These are the main parameters for a drug to be accepted by regulators and scientists also have to think one step ahead to look at the impacts of formulation on manufacturing and drug delivery. Besides the complexity of proteins, formulation needs to be robust and count on clear processes which can guarantee the quality of the product, reproducibility, efficacy in fighting against targeted cells, and stability throughout the whole process. Thanks to technical and analytical tools, protein formulation and process development is becoming more efficient. Drug deliveries and drug administration routes are also undergoing a process of innovation.

Your safety is our top priority. Click HERE to find out how we are ensuring our events are a safe place to be.

Can’t physically attend this conference?

Don’t worry we have you covered! If your ability to travel is restricted we know your appetite for key business insights remains so our Live+ digital platform enables you to fully participate in the event remotely. Of course it provides access to live online streams of all session, but much more than that, it ensures you are able to engage with speakers directly allowing you to participate in Q&A, relevant breakout groups as well as event polling and other insights and resources delivered during the event. We realise interacting with other delegates is key to your event experience, so our innovate online solution allows you to set up online meetings with other virtual and physical attendees throughout the event; ensuring you still walk away with those key contacts that can make a tangible difference to you and your business. The platform will continue to host all event content on-demand for you to re-visit and continue to access for up to 6 months post event.

Your content. Your way.


Key Topics

  • Sanofi Pasteur explore how to optimise formulation and stability prediction for biologics
  • Coriolis Pharma examine the challenges of measuring aggregation and conformational changes for biologics
  • Janssen address challenges around the formulation and stability of non-protein biological molecules
  • Queen’s University Belfast explain how 3D printed devices can improve biopharmaceutical drug delivery
  • Previous Attendees Include

    • GlaxoSmithKline
    • Pfizer
    • Abbvie
    • Roche Biologics
    • UCB
    • Sandoz
    • Abbott
    • Baxter
    • Novartis Vaccines
    • Sanofi aventis
    • Boehringer Ingelheim
    • Medimmune
    • Bayer
    • Bristol-Myers Squibb
    • Genentech
    • Janssen Pharmaceutical
    • Merck & Co
    • Novo Nordisk
    • University of Cambridge


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.


    Event Sponsors
    Visit website >>
    Visit website >>


    Event Partners


    Practical Insights From

    Carsten Worsøe
    Principal Scientist, Extractables and Leachables
    Novo Nordisk

    Dr. Martin Hülsmeyer
    Senior Principal Scientist, Head of HTS Operations and Analytics
    AbbVie

    Jonas Fransson
    Director, Drug Product Development
    Swedish Orphan Biovitrum

    Olivier Brass
    Senior Scientist, Head of Research Unit
    Sanofi Pasteur

    Dr. Klaus Richter
    Expert Scientist and Group Leader AUC
    Coriolis Pharma

    Dimitrios Lamprou
    Reader in Pharmaceutical Engineering
    Queen’s University Belfast

    Jörg Plaschke
    Lab Head, Biologics Formulation Development
    Merck

    Benjamin Werner
    Scientist, Formulation Development
    Boehringer Ingelheim

    Click Here For Full Agenda

    Voice of Our Customers
    • “The conference was very interesting – all the topics presented have been very useful!”, Genzyme
    • “Really enjoyed the speakers & interactivity of the event!”, Ipsen
    • “One of the best meetings I’ve attended. Excellent organisation, topics and speakers”, GSK
    • “High quality agenda and fantastic speakers, I would definitely attend again”, Roche
    Latest Conference News & Resources



    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Constandinos Vinall


    marcus evans (Europe) Ltd
    PO Box 24797
    1304 Nicosia, Cyprus

    Telephone:
    +357 22849 380
    Fax: +357 22849 394
    Email: constandinosv@marcusevanscy.com